Credit Suisse

From Spanish banks to Greek elections to the ECB/China/IMF saving the world rumor du jour, there has been a flurry of headlines out of Europe for the better part of the last year and it is these headlines that have been moving the market. There is reason to be alarmed and to fear, not from a Greek...

Credit Suisse reiterates its Neutral rating on Royal Bank of Canada (NYSE: RY) and reduces its price target from C$57 to C$56. Credit Suisse comments, "One of the negative surprises in the quarter was an uptick in commercial credit losses that RY attributed to two specific loans. These can be...

Credit Suisse resumes coverage on Carrizo Oil & Gas (NASDAQ: CRZO) with a Neutral rating and a price target of $30. Credit Suisse notes, "Reinstating Coverage, Transition to Liquids Continues. With the recent closing of its non-operated Barnett divestiture (closed on 5/1/12), CRZO is now...

Credit Suisse initiates its coverage on OCZ Technology Group (NASDAQ: OCZ) with a rating of Outperform and a price target of $8 per share. Credit Suisse notes, "OCZ is well positioned to benefit from the rapid growth of SSD adoption while simultaneously transforming the quality of its revenue...

Credit Suisse raises its price target on Aon (NYSE: AON) from $49 to $51 and reiterates its Neutral rating on shares. Credit Suisse comments, "Aon recently became the first company within the S&P 500 to re-domicile to the U.K. from the U.S. Based on our analysis of the accounting regime in...

Credit Suisse reduces its price target on NetApp (NASDAQ: NTAP) from $45 to $30 and maintains its Neutral rating on shares. Credit Suisse says, "Following concerning guidance, we substantially lower our FY13 EPS by 22% to $2.14, and introduce our FY14 EPS estimate of $2.26. …Management...

Credit Suisse cuts its price target on Dell (NASDAQ: DELL) from $16 to $14 as it reiterates an Underperform rating on shares. Credit Suisse says, "Lowering EPS and TP, challenging times ahead. We lower our Dell EPS by 8% for FY13 to $1.90 following the company's Q1FY13 results. Our FY14 EPS...

Credit Suisse initiates its coverage on Jazz Pharmaceuticals (NASDAQ: JAZZ) with an Outperform rating and a price target of $65. Credit Suisse comments, "We rate JAZZ Outperform because it offers (1) organic growth of the Xyrem franchise, driven by volume growth, pricing power and what we see as...

Credit Suisse has published a research report on China Telecom (NYSE: CHA) and has upgraded the company from Neutral to Outperform in expectation of an earnings recovery for the stock. In the report, Credit Suisse writes, "Our survey and store visits show that China Telecom's network and retail...

Credit Suisse cuts its price target on Outperform-rated JP Morgan Chase (NYSE: JPM) from $55 to $50 following the announcement that share buybacks were put on hold. Credit Suisse notes, "JPMorgan announced that share buyback is on hold for the time being. We are lowering our forecasts to reflect...